How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bulk Vitamin D2 Market
- By Form: Powder, Oil Suspension, Liquid, Granules
- By Application: Dietary Supplements, Pharmaceuticals, Food & Beverages, Animal Feed
- By Source: Ergosterol-derived, Synthetic
- By Purity Grade: Food Grade, Pharmaceutical Grade, Feed Grade
- By Packaging Type: Bags, Drums, Bulk Containers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Powder leads By Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 275 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Bulk Vitamin D2 Market report
A complete, evidence-based study - 12 chapters and 115 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Form 4
Application 4
Source 2
Purity Grade 3
Packaging Type 3
Companies profiled
DSM Nutritional Products
BASF SE
CSPC Pharmaceutical Group
Fermenta Biotech Ltd.
Jiangsu Yabang Dyestuff Co. Ltd.
Zhejiang NHU Co. Ltd.
Hubei Guangji Pharmaceutical Co. Ltd.
Luye Pharma Group
Jiangsu Kanion Pharmaceutical Co. Ltd.
Shandong Luwei Pharmaceutical Co. Ltd.
Jiangxi Tianxin Pharmaceutical Co. Ltd.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →DSM Nutritional Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →CSPC Pharmaceutical Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Fermenta Biotech Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jiangsu Yabang Dyestuff Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Zhejiang NHU Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Hubei Guangji Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Luye Pharma Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Jiangsu Kanion Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shandong Luwei Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Jiangxi Tianxin Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,991M by 2033 · 11.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Powder45.2
- Oil Suspension13.1
- Liquid18.7
- Granules23.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,391M → $3,444M · 12.0%
Europe$969.8M → $2,437M · 12.2%
Asia Pacific$885.4M → $2,262M · 12.4%
Latin America$548.1M → $1,226M · 10.6%
Middle East and Africa$421.6M → $996.2M · 11.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.342026
11.362027
11.362028
11.372029
11.382030
11.402031
11.402032
11.422033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- DSM Nutritional Products28.5
- BASF SE9.0
- CSPC Pharmaceutical Group7.2
- Fermenta Biotech Ltd.7.9
- Jiangsu Yabang Dyestuff Co. Ltd.7.3
- Zhejiang NHU Co. Ltd.12.2
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Form14.3%
Application20.5%
Source25.5%
Purity Grade20.9%
Packaging Type18.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe23.5
- Asia Pacific21.8
- Latin America11.8
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| DSM Nutritional Products | 76 | 89 | 95 | 81 | 75 | 87 | 84 |
| BASF SE | 82 | 90 | 87 | 85 | 74 | 72 | 82 |
| CSPC Pharmaceutical Group | 81 | 84 | 70 | 72 | 82 | 86 | 79 |
| Fermenta Biotech Ltd. | 79 | 82 | 62 | 71 | 77 | 73 | 74 |
| Jiangsu Yabang Dyestuff Co. Ltd. | 73 | 76 | 53 | 60 | 68 | 53 | 64 |
| Zhejiang NHU Co. Ltd. | 67 | 46 | 46 | 51 | 59 | 70 | 57 |
| Hubei Guangji Pharmaceutical Co. Ltd. | 41 | 46 | 65 | 43 | 55 | 56 | 51 |
| Luye Pharma Group | 58 | 56 | 43 | 36 | 52 | 55 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- DSM Nutritional Products
- BASF SE
- CSPC Pharmaceutical Group
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| DSM Nutritional Products | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| BASF SE | ✓ | ◐ | ◐ | ✓ | ✓ | − |
| CSPC Pharmaceutical Group | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Fermenta Biotech Ltd. | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Jiangsu Yabang Dyestuff Co. Ltd. | − | ◐ | − | ◐ | ◐ | − |
| Zhejiang NHU Co. Ltd. | ◐ | ◐ | − | − | ◐ | − |
| Hubei Guangji Pharmaceutical Co. Ltd. | − | ◐ | ◐ | − | − | ◐ |
| Luye Pharma Group | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1DSM Nutritional Products84
2BASF SE82
3CSPC Pharmaceutical Group79
4Fermenta Biotech Ltd.74
5Jiangsu Yabang Dyestuff Co. Ltd.64
6Zhejiang NHU Co. Ltd.57
7Hubei Guangji Pharmaceutical Co. Ltd.51
8Luye Pharma Group50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
DSM Nutritional ProductsBASF SECSPC Pharmaceutical Group
Challenger1
Strong scale, closing on the leaders.
Fermenta Biotech Ltd.
Contender2
Focused players with pockets of strength.
Jiangsu Yabang Dyestuff Co. Ltd.Zhejiang NHU Co. Ltd.
Niche2
Specialists in a single segment or region.
Hubei Guangji Pharmaceutical Co. Ltd.Luye Pharma Group
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Form in North America, then scale across Bulk Vitamin D2 Market — a $653M beachhead inside a $10.9B market.
Beachhead (SOM)$653Mobtainable near-term
Serviceable (SAM)$3.98Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Powder
Best fit — highest urgency & budget in Form.
Economic buyer77 fit
Oil Suspension
Strong fit — clear ROI and a fast path to value.
End user65 fit
Liquid
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Source
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bulk Vitamin D2 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified21%
Evaluation12%
Closed-won6%
$10.8KCAC
$46KLTV
4.2:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bulk Vitamin D2 Market is a durable-growth opportunity — $847M by 2033, compounding at 9.6%.
TAM · 2025$406Mtoday
TAM · 2033$847Mforecast
CAGR9.6%2027–2033
Cumulative$5.43Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$847MTotal addressable market
SAM$320MServiceable available market
SOM$67MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.6% CAGR
Demand compounds through 2033, outpacing GDP across Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Form moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$847MLarge & growingTAM by 2033 at 9.6% CAGR
$320MServiceable nowreachable with today’s model
$67MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$661MBear6.3% CAGR
$847MBase9.6% CAGR
$1.08BBull12.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bulk Vitamin D2 Market — a $5.18B market by 2033. Plan: grow share from 8.6% to 13.9%.
Market size · 2033$5.18Btotal addressable
Market CAGR5.2%2027–2033
Target share13.9%from 8.6% today
Revenue ambition$720Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.6% | 13.9% | At risk |
| Revenue | $479M | $720M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.8% | 42.6% | Ahead |
| Customer retention | 87.6% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $104M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bulk Vitamin D2 Market conversation — a $3.29B market you can size, segment and defend in minutes.
Market size · 2033$3.29Btotal opportunity
Growth9.7%CAGR to 2033
Addressable buyers1,686+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Form
Goal Grow share in Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 3 mopayback period
$49K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
DSM Nutritional ProductsBASF SECSPC Pharmaceutical GroupFermenta Biotech Ltd.Jiangsu Yabang Dyestuff Co. Ltd.Zhejiang NHU Co. Ltd.Hubei Guangji Pharmaceutical Co. Ltd.Luye Pharma Group+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bulk Vitamin D2 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bulk Vitamin D2 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bulk Yarn Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBulk/HOD Water (Soft drinks) Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportBulked Glass Yarn Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBull Screen Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportBulldozers And Angle Dozers Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBulldozers Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportBullet Resistant Polycarbonate Sheet Market
Market size, share, segmentation and regional forecast.
$761M market · 2025 base year
View reportBullet Train/High-Speed Rail Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportbulletproof plate Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBulletproof Vests Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBullous Pemphigoid Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportB-Ultrasonic Printer Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.